NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
Back to search
Official data from USPTO
KEROS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
KEROS THERAPEUTICS
ST13
US500000088949510Class
5
Filing
88949510
Registration
7502544
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
09/10/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/05/2020
Registration date
09/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
09/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/16/2023
First use in commerce
05/16/2023
Drawing code
4
Owner type
03
Owner location
Lexington, MA, US
Examiner
FROMM, MARTHA L
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Keros Therapeutics, Inc.
Representatives
Michael J. Belliveau CLARK+ELBING LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of hematological disorders
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/08/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2024
ALIE
ASSIGNED TO LIE
06/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
02/02/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
02/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2023
GNRT
NON-FINAL ACTION E-MAILED
11/03/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/03/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/25/2023
IUAF
USE AMENDMENT FILED
10/20/2023
EISU
TEAS STATEMENT OF USE RECEIVED
10/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/24/2023
EX5G
SOU EXTENSION 5 GRANTED
06/23/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/20/2023
EXT5
SOU EXTENSION 5 FILED
06/13/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2022
EX4G
SOU EXTENSION 4 GRANTED
12/09/2022
EXT4
SOU EXTENSION 4 FILED
12/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/18/2022
EX3G
SOU EXTENSION 3 GRANTED
06/16/2022
EXT3
SOU EXTENSION 3 FILED
06/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/16/2021
EX2G
SOU EXTENSION 2 GRANTED
12/14/2021
EXT2
SOU EXTENSION 2 FILED
12/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/23/2021
EX1G
SOU EXTENSION 1 GRANTED
06/21/2021
EXT1
SOU EXTENSION 1 FILED
06/21/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2020
PUBO
PUBLISHED FOR OPPOSITION
10/27/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2020
DOCK
ASSIGNED TO EXAMINER
09/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/26/2020
Continuous trademark protection
Get notified about every new filing that threatens KEROS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.